Skip to content
Log in
Sponsored AI Networking Cookbook: Practical recipes for AI-assisted network automation and development AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
Open access

Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways that Potentiate and Limit Antitumor Immunity

Daniel R Lu T. Osgood Shining Ma Huajia Zhang Matt Kanke Jessica A. Tan Siddhi N. Paudel Hong Zhou Juan Estrada Tracy Yamawaki K. Tarbell Karen Rex J. DeVoss Scott E Martin Songli Wang Jude Canon J. Lipford A. Coxon Chi-Ming Li
Jul 2026 · Cancer immunology research · Vol 14, pp. 1433 - 1453 · 0 citations · 77 references
Medicine

Abstract

Using KRAS and MEK inhibition, the authors demonstrate altered neoplastic cell fates and immune functions of cDCs, T cells, and macrophages. Addition of KRAS inhibition to PD-1 blockade enhances T cell– and macrophage-mediated antitumor immunity.

DOI PubMed Semantic Scholar
Read PDF

Similar papers

Open access Sep 2026

TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment

Evidence is provided for a key role of TNFR1, as expressed by malignant cells, in orchestrating a pro-tumor immunosuppressive environment through secondary inflammatory mediators through secondary inflammatory mediators.

Elixabet Bolaños, Lorena Cañas-Zabala, Irene Olivera et al. · 0 citations
Open access Aug 2026

CD1d remodels the tumor-infiltrating myeloid populations controlling antitumor immunity

CD1d targeting reshapes tumor immune infiltrates, suppresses tumor growth, and enhances immunotherapy efficacy, suggesting an actionable pathway for therapeutic intervention.

Lauren Evans, Maria Conde Poole, Cenk Celik et al. · 0 citations
Open access Sep 2026

STAT3 inhibition for the induction of immunogenic cell death in multiple myeloma

It is reported that STAT3 inhibition eliminates multiple myeloma stem-like cells while eliciting hallmarks of immunogenic cell death, yet in vivo validation remains necessary before this strategy can be considered immunogenic.

O. Kepp, G. Kroemer · 0 citations
Open access Aug 2026

CCT2 Promotes Immune Escape in Colorectal Cancer by Regulating the JAK1‐STAT3‐PD‐L1 Axis

This study explored the molecular mechanisms underlying CRC immune evasion as well as the therapeutic effects of immune checkpoint inhibitors in microsatellite‐stable/proficient mismatch repair CRC.

Li-Qiang Gu, Shao-Fei Li, Yi-Chao Tang et al. · 0 citations
Aug 2026

Statins suppress colon tumors by inhibiting KRAS condensates.

It is reported that farnesylation-induced KRAS phase separation drives colon cancer progression and resistance to G12C inhibitors and statins can block this process, suppress tumor growth, and reverse drug resistance.

Zhuangzhuang Yuan, Chenyu Wang, Rong Xiang · 0 citations
Open access Aug 2026

Foretinib triggers immunogenic cell death and enhances efficacy of anti-CD47 immunotherapy in colorectal cancer

The dual-target c-Met/VEGFR kinase inhibitor foretinib reshapes tumor immune microenvironment (TIME) by inducing immunogenic cell death (ICD) and the combination of foretinib with anti-CD47 antibody significantly inhibits tumor growth in colon cancer model.

Lin Li, Nannan Zhu, Tao Zhu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.